Literature DB >> 8611035

Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver.

P F Sterchele1, H Sun, R E Peterson, J P Vanden Heuvel.   

Abstract

Chemical-induced peroxisome proliferation in rodent liver is postulated to occur via activation of members of the steroid hormone receptor superfamily, the peroxisome proliferation-activated receptors (PPARs). In the present study, the expression of the predominant liver subtype PPAR alpha was examined and compared to that of acyl-CoA oxidase (ACO), a marker for peroxisome proliferation and a prototype for genes regulated via PPARs. Despite the induction of both mRNA species in vivo by the peroxisome proliferator perfluorodecanoic acid (PFDA), dose response and time course indicate PPAR alpha and ACO are not controlled similarly. Messenger RNA levels for ACO increased rapidly in rat liver and declined over the subsequent 7 days following PFDA administration, while PPAR alpha mRNA increased slower and remained elevated over this period. In addition, PPAR alpha mRNA accumulation in PFDA-treated rats appears to be due primarily to hypophagia as pair feeding and complete caloric restriction result in a large increase in the concentration of this messenger RNA. Nuclear run-on experiments in vivo suggest that, unlike ACO, PFDA as well as caloric restriction results in accumulation of PPAR alpha mRNA which cannot be explained solely by transcriptional activation. These data indicated that PPAR alpha mRNA accumulation has a very small peroxisome proliferator-dependent component and that other factors may be involved. A rat hepatoma cell line was examined to determine the direct effect on peroxisome proliferators on PPAR alpha mRNA. PPAR alpha and ACO mRNA levels were increased rapidly in the rat hepatoma cell line FaO after treatment with PFDA or the prototypical peroxisome proliferator Wy 14,643. In this cell line, PPAR alpha mRNA levels are not affected by glucagon or insulin and in addition to peroxisome proliferators are induced in this cell line by oleic acid and dexamethasone. The latter treatment had the greatest effect on PPAR alpha mRNA accumulation while having a minimal effect on ACO mRNA. Treatment of FaO cells with actinomycin D prior to Wy 14,643 abolished ACO and PPAR alpha mRNA accumulation, demonstrating that there must be a transcriptional component of the peroxisome proliferator response. Therefore, although PPAR alpha is responsive to peroxisome proliferators and direct effects are observed in cell cultures, mRNA accumulation in vivo is predominantly posttranscriptional, and endogenous regulators such as glucocorticoids may play critical roles in the tissue- and developmentally specific expression of this steroid hormone receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611035     DOI: 10.1006/abbi.1996.0077

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Increased peroxisomal fatty acid beta-oxidation and enhanced expression of peroxisome proliferator-activated receptor-alpha in diabetic rat liver.

Authors:  K Asayama; R Sandhir; F G Sheikh; H Hayashibe; T Nakane; I Singh
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

2.  PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells.

Authors:  N Marx; G K Sukhova; T Collins; P Libby; J Plutzky
Journal:  Circulation       Date:  1999-06-22       Impact factor: 29.690

3.  A novel cutaneous Fatty Acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells.

Authors:  Zhengzheng Bao; Mohammad I Malki; Shiva S Forootan; Janet Adamson; Farzad S Forootan; Danqing Chen; Christopher S Foster; Philip S Rudland; Youqiang Ke
Journal:  Genes Cancer       Date:  2013-07

4.  Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid.

Authors:  Jonathan M Maher; Lauren M Aleksunes; Matthew Z Dieter; Yuji Tanaka; Jeffrey M Peters; Jose E Manautou; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2008-08-29       Impact factor: 4.849

5.  Down-regulation of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase by polyunsaturated fatty acids in hepatocytes is not mediated by PPARalpha.

Authors:  Naho Sasaki; Yukari Egashira; Hiroo Sanada
Journal:  Eur J Nutr       Date:  2008-03-04       Impact factor: 5.614

6.  Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells.

Authors:  Y T Zhou; M Shimabukuro; M Y Wang; Y Lee; M Higa; J L Milburn; C B Newgard; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

7.  Systems analysis of small signaling modules relevant to eight human diseases.

Authors:  Kelly F Benedict; Feilim Mac Gabhann; Robert K Amanfu; Arvind K Chavali; Erwin P Gianchandani; Lydia S Glaw; Matthew A Oberhardt; Bryan C Thorne; Jason H Yang; Jason A Papin; Shayn M Peirce; Jeffrey J Saucerman; Thomas C Skalak
Journal:  Ann Biomed Eng       Date:  2010-12-04       Impact factor: 3.934

8.  Extracts of Rhizoma polygonati odorati prevent high-fat diet-induced metabolic disorders in C57BL/6 mice.

Authors:  Ming Gu; Yu Zhang; Shengjie Fan; Xiaobo Ding; Guang Ji; Cheng Huang
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

9.  A Moderate Zinc Deficiency Does Not Impair Gene Expression of PPARα, PPARγ, and Mitochondrial Enoyl-CoA Delta Isomerase in the Liver of Growing Rats.

Authors:  Jennifer Justus; Edgar Weigand
Journal:  Nutr Metab Insights       Date:  2014-05-05

10.  Liver-specific overexpression of lipoprotein lipase improves glucose metabolism in high-fat diet-fed mice.

Authors:  Kahori Shimizu; Syogo Nishimuta; Yuri Fukumura; Shotaro Michinaga; Yuka Egusa; Tomomi Hase; Tomoyuki Terada; Fuminori Sakurai; Hiroyuki Mizuguchi; Koji Tomita; Toru Nishinaka
Journal:  PLoS One       Date:  2022-09-13       Impact factor: 3.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.